
AI Model May Predict Immunotherapy Responses in Advanced NSCLC
A deep learning–based artificial intelligence (AI) response stratification model—Deep-IO—may predict responses to immune checkpoint inhibitors (ICIs) across different cohorts of patients with advanced non–small cell lung cancer (NSCLC), according to …